搜索结果: 1-15 共查到“Lung-Cancer”相关记录54条 . 查询时间(0.14 秒)
Data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer（图）
晚期肺癌 免疫治疗 停止治疗
2023/6/27
Over the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment for patients with advanced lung cancer, helping many live longer lives and improving overall survival fo...
Immunotherapy — drug treatment that stimulates the immune system to attack tumors — works well against some types of cancer, but it has shown mixed success against lung cancer.
MIT researchers develop an AI model that can detect future lung cancer risk（图）
人工智能模型 检测肺癌风险 深度学习
2023/6/20
The name Sybil has its origins in the oracles of Ancient Greece, also known as sibyls: feminine figures who were relied upon to relay divine knowledge of the unseen and the omnipotent past, present, a...
NGAOUNDERE AND YAOUNDE, CAMEROON – When Bobbo Hamadou gets up in the morning, he opens the door and window in his house. This is not just to air out his mattress – but to lower the concentration of ra...
徐州市实验诊断学重点实验室在《Translational Lung Cancer Research》杂志发表最新研究成果（图）
徐州市 实验诊断学 重点实验室 Translational Lung Cancer Research 杂志 最新研究成果
2020/7/14
近日，肺癌转化研究领域国际权威杂志《Translational Lung Cancer Research》（中科院医学一区、呼吸系统一区）在线发表了由徐州市实验诊断学重点实验室顾兵教授团队、徐州医科大学附属医院呼吸与危重医学科陈碧主任医师团队合作的题为《Characterization of the lung microbiome and exploration of potential bact...
上海交通大学医学院内科学课件 lung cancer
上海交通大学医学院 内科学 课件 lung cancer
2016/12/27
上海交通大学医学院内科学课件 lung cancer。
The conflicting evidence of the relation
between b-carotene and lung cancer in humans serves as a
poignant case study with respect to what types of evidence are
sufficient to support or change a nu...
Lung cancer screening: Summary of the evidence and the 2013 US Preventative Services Task Force recommendations
Lung cancer screening Summary of the evidence the 2013 US Preventative Services Task Force
2015/4/17
The United States Preventative Services Task Force is an independent panel of non-Federal experts in prevention and evidence-based medicine that reviews scientific studies and makes recommendations on...
Lung cancer
Lung cancer surgery
2015/4/8
Almost untreatable in 1973, except by surgery, lung cancer is now susceptible to radiotherapy and chemotherapy as
well, and is often treated by all three modalities in combination. Although tobacco ...
Evolution of biological therapies in non-small cell lung cancer
biological therapies non-small cell lung cancer
2015/3/26
This article explores recent clinical developments of biological or targeted therapies in non-small cell lung cancer. Molecular research has given us a greater understanding of tumour biology and has ...
Non-small cell lung cancer in the elderly - systemic therapy
Non-small cell lung cancer elderly - systemic therapy
2015/3/26
Elderly patients represent a significant and rising proportion of patients with Non-Small Cell Lung Cancer and historically they have been under-treated and under-represented in clinical trials. Incre...
A technique which can detect a growing pulmonary malignancy when it is small should allow more effective therapy and a better outcome for patients. Henschke and her colleagues in the Early Lung Cancer...
FDG PET: Revolution or evolution in the management of non-small cell lung cancer?
Revolution evolution management of non-small cell lung cancer
2015/3/11
Lung cancer is currently the leading cause of cancer-related death in both men and women in most Western countries. In Australia there is a falling incidence in males that is not matched in females, t...
Contemporary management of non-small cell lung cancer in Australia
Contemporary management non-small cell lung cancer Australia
2015/3/11
In 1955, Bromley and Szur reported on 66 patients with a pathologic diagnosis of lung cancer who had been treated with high dose radiotherapy and who had then proceeded to surgery1. In 24 (46.7%) no t...
Systemic therapy of lung cancer: where are we in 2002?
Systemic therapy lung cancer where are we in 2002
2015/3/11
At a time when our understanding of the molecular biology of cancer was supposed to lead to major advances in therapy, it is disappointing to report that the major lung cancer ‘story’ of 2002 (table o...